Sagimet Biosciences (SGMT) Set for 273% Surge After Buy Rating
Sagimet Biosciences Inc. (NASDAQ:SGMT) is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies that target the underlying…
Browsing Tag